Empresa Eledon Pharmaceuticals, Inc.
Acciones
ELDN
US28617K1016
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,41 USD | +4,78 % | +16,99 % | +33,89 % |
Resumen de negocios
Número de empleados: 20
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 51 | 01/05/20 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 15/03/21 |
Steven N. Perrin
PSD | President | 59 | 14/09/20 |
Eliezer Katz
CTO | Chief Tech/Sci/R&D Officer | - | 23/10/23 |
John Herberger
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/22 |
Bryan E. Smith
CMP | Compliance Officer | 45 | 19/04/21 |
David Hovland
LAW | General Counsel | - | 19/04/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 01/05/17 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 14/09/20 |
John S. McBride
BRD | Director/Board Member | 72 | 01/05/17 |
Steven N. Perrin
PSD | President | 59 | 14/09/20 |
Chief Executive Officer | 51 | 01/05/20 | |
James Robinson
BRD | Director/Board Member | 54 | 01/10/23 |
June Lee
BRD | Director/Board Member | 58 | 09/12/20 |
Jan Hillson
BRD | Director/Board Member | 71 | 02/07/21 |
Allan Kirk
BRD | Director/Board Member | - | 02/10/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 110 086 | 0 | 0 | 94,57 % |
Acción B | 1 | 24 813 130 | 23 466 868 ( 94,57 %) | 0 | |
Acción C | 0 | 4 422 | 0 | 0 |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+33,89 % | 59,8 M | |
-1,43 % | 104 mil M | |
+8,96 % | 105 mil M | |
+4,40 % | 22,94 mil M | |
-12,15 % | 22,34 mil M | |
-4,36 % | 19,25 mil M | |
-39,98 % | 17,08 mil M | |
-10,04 % | 16,96 mil M | |
+6,79 % | 14,16 mil M | |
+38,61 % | 12,63 mil M |
- Bolsa de valores
- Acciones
- Acción ELDN
- Empresa Eledon Pharmaceuticals, Inc.